| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |